Skip to content
Dosage GuideResearch Reference

PEG-MGF Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for PEG-MGF. All information is for educational purposes only.

Quick Answer

In preclinical research, PEG-MGF is typically administered at 100–400 mcg per dose, 1–2 times weekly via subcutaneous or intramuscular injection. Dosing frequency is lower than standard MGF due to its extended half-life from pegylation. No human clinical dose-ranging trials have been completed.

→ PEG-MGF Benefits→ PEG-MGF Side Effects→ Full PEG-MGF Profile
Table of Contents

Standard Dosage Range

Research dosing range: 100–400 mcg per dose (injection)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Muscle Injury Recovery (strains, tears)

200–400 mcg1–2× weekly
Duration

4–8 weeks

Inject subcutaneously or intramuscularly near the injury site. Some protocols may use localized injection, others systemic due to PEG modification.

Muscle Hypertrophy (adjunct to resistance training)

100–300 mcg1× weekly
Duration

4–8 weeks

Administer subcutaneously or intramuscularly post-workout. Monitor for potential IGF-1 related side effects (though less pronounced than with rhIGF-1).

Sarcopenia (age-related muscle loss)

100–200 mcg1× weekly
Duration

8–12 weeks

Subcutaneous or intramuscular injection. Research is preliminary; safety and efficacy not fully established in humans.

Timing & Frequency

For muscle recovery and hypertrophy, injections are typically administered post-workout. Due to the extended half-life, timing is less critical than with standard MGF. A single weekly dose provides sustained satellite cell activation.

Cycle Guidance

Preclinical studies suggest benefits from 4–8 week cycles. A common research practice is an 8-week cycle followed by a 4-week break. Potential downstream IGF-1 effects warrant caution. Cycling is advised until further human data is available.

Reconstitution Reference

Quick reference for reconstituting PEG-MGF. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1 mg or 2 mg per vial
BAC Water Volume1 mL bacteriostatic water for 1 mg/mL or 2 mg/mL concentration, respectively
Concentration & DrawAt 1 mg/mL: 100 mcg = 0.1 mL (10 units on a 100-unit insulin syringe). At 2mg/mL: 100mcg = 0.05mL (5 units on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 30 days refrigerated. Lyophilized powder stable 12–24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the best PEG-MGF dosage for muscle growth?
Preclinical research suggests 100-300 mcg once weekly, administered post-workout may be beneficial. Human trials are needed to validate this dosage. Start low and monitor for side effects.
How long does PEG-MGF stay in your system?
Due to pegylation, PEG-MGF has an extended half-life of several days compared to standard MGF. This allows for less frequent dosing.
Can PEG-MGF cause gynecomastia?
PEG-MGF can potentially exert downstream IGF-1 like effects. Though less pronounced than with direct IGF-1 administration, gynecomastia is a theoretical risk. Lower doses and careful monitoring are advised.

Last updated: 2026-02-19